Pages that link to "Q64785039"
Jump to navigation
Jump to search
The following pages link to Francesca Maria Rossi (Q64785039):
Displaying 50 items.
- Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation (Q28244717) (← links)
- Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia (Q28394721) (← links)
- Cluster analysis of immunophenotypic data: the example of chronic lymphocytic leukemia. (Q33711084) (← links)
- CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation. (Q33747241) (← links)
- Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells (Q33758834) (← links)
- Interaction blues: protein interactions monitored in live mammalian cells by beta-galactosidase complementation. (Q33838290) (← links)
- CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study. (Q35717883) (← links)
- Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. (Q36324006) (← links)
- Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia (Q36420752) (← links)
- Microenvironmental interactions in chronic lymphocytic leukemia: the master role of CD49d. (Q38232480) (← links)
- 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia (Q38491230) (← links)
- Functional and Clinical Significance of the Integrin Alpha Chain CD49d Expression in Chronic Lymphocytic Leukemia (Q38925105) (← links)
- Competitive reverse-transcriptase PCR: a useful alternative to northern blotting for quantitative estimation of relative abundances of specific mRNAs in precious samples. (Q42987269) (← links)
- Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia (Q43558209) (← links)
- A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: a single institution experience. (Q43688251) (← links)
- CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival (Q44276636) (← links)
- Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia. (Q44752987) (← links)
- Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome (Q46585922) (← links)
- PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy. (Q47608454) (← links)
- CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias (Q47836845) (← links)
- NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types. (Q48140340) (← links)
- Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia (Q48307279) (← links)
- Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia. (Q51025698) (← links)
- Differential expression of the RET gene in human acute myeloid leukemia. (Q52181394) (← links)
- Ibrutinib-naïve chronic lymphocytic leukemia lacks Bruton tyrosine kinase mutations associated with treatment resistance. (Q52993622) (← links)
- CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia. (Q53465248) (← links)
- NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. (Q54345184) (← links)
- Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. (Q54704847) (← links)
- Improved GMP compliant approach to manipulate lipoaspirates, to cryopreserve stromal vascular fraction, and to expand adipose stem cells in xeno-free media. (Q55375632) (← links)
- Expression of Mutated IGHV3-23 Genes in Chronic Lymphocytic Leukemia Identifies a Disease Subset with Peculiar Clinical and Biological Features (Q58000969) (← links)
- Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study (Q58001001) (← links)
- CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism (Q58319764) (← links)
- Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia (Q60358020) (← links)
- Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome (Q60358350) (← links)
- Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia (Q60358460) (← links)
- ZAP-70 expression in B-cell chronic lymphocytic leukemia: Evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgVH mutations (Q60358588) (← links)
- Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease (Q64124611) (← links)
- Flow cytometric technique for quantitating cytotoxic response to photodynamic therapy (Q70941887) (← links)
- A recipe for the preparation of a rodent food that eliminates chlorophyll-based tissue fluorescence (Q71512406) (← links)
- Epidermal growth factor receptor dimerization monitored in live cells (Q73405755) (← links)
- Cytokine-receptors repertoire in a pre-osteoclast cell line (Q73497738) (← links)
- Practical Method for the Multigram Separation of the 5- and 6-Isomers of Carboxyfluorescein (Q73589992) (← links)
- Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of beta2-microglobulin: molecular monitoring of minimal residual disease in acute promyelocytic leukemia (Q73887103) (← links)
- Human granulocyte-macrophage colony-stimulating factor supports the clonogenic growth of B-lineage acute lymphoblastic leukemias expressing myeloid antigens (Q74030794) (← links)
- Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells (Q74459525) (← links)
- Hodgkin's disease: a disorder of dysregulated cellular cross-talk (Q74562571) (← links)
- CD30L up-regulates CD30 and IL-4 expression by T cells (Q77307649) (← links)
- A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines (Q92022521) (← links)
- KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival (Q92372468) (← links)
- <i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation (Q101118296) (← links)